1. Market Research
  2. > Therapy Industry

Cancer Immunotherapy Industry, March 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Chemotherapy, Lung Cancer, Nuclear Medicine, Cancer, Infectious Disease, Leukemia, Pancreatic Cancer.


 
1-10 of 18 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers

Personalized Cancer Vaccines Market & Clinical Innovation Outlook 2022

Personalized Cancer Vaccines Market & Clinical Innovation Outlook 2022

  • $ 2000
  • Industry report
  • February 2017
  • by Kuick Research

Oncological segment has gained a great momentum with the advent of modern technologies and the better equipped sequencing methodology. Over the past years, there has been gradual paradigm shift from traditional ...

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Cancer Immunotherapy Market: Overview The growing incidences of cancer and a need to treat them is the key driver of the global immunotherapy market. The number of deaths occurring due to cance ...

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market

  • $ 4995
  • Industry report
  • December 2016
  • by GBI Research

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market Summary Cancer is a group of diseases characterized ...

Cancer Immunotherapy - Global Market Outlook (2016-2022)

Cancer Immunotherapy - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Cancer Immunotherapy market is estimated at $54.35 billion in 2015 and is expected to reach $147.25 billion by 2022 growing at a CAGR of 15.3% from 2015 to 2022. ...

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Cancer Immunotherapy: Analytical Tool

Cancer Immunotherapy: Analytical Tool

  • $ 8750
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update

  • $ 2250
  • Industry report
  • August 2016
  • by Bioseeker

BioSeeker’s Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and ...

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates , Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor  T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates , Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint

  • $ 3800
  • Industry report
  • July 2016
  • by Kelly Scientific Publications

This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic ...

Global Cancer Immunotherapies Market 2016-2020

Global Cancer Immunotherapies Market 2016-2020

  • $ 2500
  • Industry report
  • April 2016
  • by Infiniti Research Limited

About Cancer Immunotherapies Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies ...

About 2600 reports for Cancer Immunotherapy

Download Unlimited Documents from Trusted Public Sources

3Legs Resources Plc - Annual Report, 2016

  • January 2016
    117 pages
  • United Kingdom  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.